Welcome to our dedicated page for Cannabix Technol news (Ticker: BLOZF), a resource for investors and traders seeking the latest updates and insights on Cannabix Technol stock.
About Cannabix Technologies Inc.
Cannabix Technologies Inc. (OTC: BLOZF) is a pioneering developer of advanced breathalyzer technologies designed to detect marijuana (delta-9 THC) and alcohol use. The company’s innovative solutions cater to critical industries, including law enforcement, workplace safety, and regulatory compliance programs. By focusing on real-time detection of substances, Cannabix addresses the growing public safety and operational challenges associated with impairment from marijuana and alcohol.
Core Technologies and Features
The company’s flagship products, including the Breath Logix Industrial and Workplace Series, are autonomous, wall-mounted breathalyzer devices equipped with cutting-edge features. These include patent-pending pre-calibrated cartridge technology, weather-resistant designs, and real-time reporting capabilities. The devices are designed for diverse applications, such as pre-access testing, random testing, start-of-shift testing, pre-employment screening, and post-incident investigations. Cannabix’s technology also integrates with biometric identification systems and access control devices, enhancing its utility in safety-sensitive environments.
Cannabix is also advancing its Marijuana Breathalyzer (CMB), which focuses on detecting recent use of delta-9 THC, the psychoactive component of marijuana. Unlike traditional methods such as urine or blood tests, which can detect THC long after impairment has subsided, Cannabix’s breathalyzer technology provides a more accurate assessment of current impairment, making it a vital tool for law enforcement and employers.
Market Applications
The company’s breathalyzer solutions are tailored for a wide range of industries, including:
- Law Enforcement: Tools to detect marijuana and alcohol impairment in real-time, addressing challenges in road safety and DUI enforcement.
- Workplace Safety: Autonomous devices to ensure compliance with substance use policies, reducing accidents and enhancing productivity.
- Regulatory Programs: Solutions for initiatives like the U.S. 24/7 Sobriety Program, which aims to reduce re-arrests through daily alcohol testing.
- Industrial and High-Risk Environments: Pre-access and random testing for sectors such as mining, oil and gas, and transportation.
Competitive Advantages
Cannabix Technologies differentiates itself through its focus on innovation and user-centric design. Key advantages include:
- Recent-Use Detection: A unique approach to marijuana testing that identifies recent use rather than residual traces, ensuring more accurate assessments of impairment.
- Autonomous Operation: Devices that operate without the need for dedicated administrators, reducing costs and improving efficiency for organizations.
- Scalability: Versatile applications across various industries and settings, from small businesses to large-scale regulatory programs.
- Regulatory Alignment: Active efforts to meet certification requirements in key markets, including the U.S., Canada, Australia, and Europe.
Industry Significance
As marijuana legalization expands globally and workplace safety remains a top priority, the demand for reliable impairment detection tools is growing. Cannabix is well-positioned to capitalize on this trend, offering solutions that bridge the gap between traditional testing methods and the need for real-time, accurate assessments. By addressing critical safety concerns, the company plays a pivotal role in enhancing public safety and operational efficiency.
Conclusion
With its innovative technologies, strategic market focus, and commitment to regulatory compliance, Cannabix Technologies Inc. is at the forefront of the evolving landscape of substance impairment detection. The company’s solutions not only improve safety but also empower organizations to implement cost-effective, efficient testing protocols, making it a key player in this critical industry.
Cannabix Technologies (CSE: BLO) (OTC PINK: BLOZF) has signed a memorandum of understanding (MOU) with AlcoPro Inc. of Knoxville, TN, to collaborate on marketing the Cannabix Marijuana Breathalyzer (CMB) technology in the United States. As part of the initial agreement, AlcoPro will feature the CMB hardware in its 2025 product catalogue, which reaches over 70,000 businesses globally.
AlcoPro, established in 1982, is a leading distributor of drug and alcohol testing instruments. The MOU aims to establish preliminary marketing exposure for the CMB to AlcoPro's customers, assess market interest, and work towards a future distribution agreement. Cannabix has recently upgraded its Breath Collection Unit (BCU), a key hardware component used for portable detection of delta-9 THC in breath, and is advancing its validation work in the United States.
Cannabix Technologies (CSE: BLO, OTC: BLOZF) has announced significant updates to its Cannabix Marijuana Breathalyzer (CMB) technology. The company has enhanced its Breath Collection Unit (BCU) with new features including a smaller, lightweight design, removable rechargeable Li-ion battery, and modified sample collection cartridge capable of single or dual sample collection.
The improvements come amid growing concerns about marijuana-impaired driving in the United States, where cannabis is now legal in 39 states for medical use and 24 states for recreational use. According to a 2019 AAA Foundation survey, approximately 14.8 million U.S. drivers reported driving within one hour of using marijuana, with 70% believing they wouldn't get caught.
The technology focuses on 'recent use' detection of delta-9 THC, unlike traditional urine, blood, and saliva tests that can detect THC weeks after consumption. New features include ambient air collection capability, periodic quality assurance checks, and a streamlined user interface.
Cannabix Technologies has received positive certification from CEcert GmbH for its Breath Logix autonomous alcohol breathalyzer. The certification follows rigorous 6-month testing under Australian Standard AS 3547.1, including alcohol, drift, climatic, electromagnetic compatibility, and vibration testing. This certification enables marketing and sales in Australia and other jurisdictions. The device features patent-pending pre-calibrated cartridge technology, autonomous sobriety checking, identity confirmation, and real-time BAC reporting. The company is partnering with Breathalyser Sales & Service Pty for distribution in Australia, targeting employers, alcohol testing facilities, and various safety-critical industries including mining, oil and gas, industrial, trucking, and warehousing.
Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) announced its participation in the upcoming Society of Forensic Toxicologists (SOFT) conference in October. Dr. Bruce Goldberger, Senior Advisor to Cannabix, will present the company's marijuana breathalyzer system at a workshop session titled 'Chasing Impairment – Advancement in Technologies or a Paradigm Shift? – You be the Judge!'
In collaboration with Omega Laboratories Inc., Cannabix has upgraded its Breath Collection Unit with new features to meet market and regulatory requirements. These include an 'on demand' quality assurance check, a startup self-check, and a new ambient air sample collection procedure. The sample collection cartridge has been modified to collect single or dual samples.
Omega scientists have successfully detected and quantified delta-9 THC in the low picogram range using Cannabix's technology. They have also developed a test method that detects, isolates, and quantifies delta-9 THC, delta-8 THC, CBN, and CBD from breath samples. The partnership aims to advance the development and commercialization of Cannabix's marijuana breathalyzer technology.
Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) has initiated advanced discussions with Smartox of Irving, Texas for potential sales distribution of its Breath Logix Alcohol screening device. The company has shipped the device for evaluation, preliminary marketing, and business development purposes. Cannabix is rapidly advancing its Breath Logix alcohol screening devices with certification, manufacturing, regulatory, and distribution relationships.
The Breath Logix device offers a fast, accurate, and autonomous alcohol screening process for workplace testing. It features a unique pre-calibrated, replaceable alcohol sensor cartridge, eliminating costly calibrations. The device integrates with third-party access control and biometric systems, potentially expanding the reach of alcohol device distributors worldwide.
Cannabix Technologies and Omega Laboratories have reported positive early results from testing their marijuana breathalyzer technology. Omega has initiated pre-validation work to establish detection limits for delta-9 THC, the primary psychoactive component of cannabis. Omega scientists have successfully quantified delta-9 THC in low picogram ranges using Cannabix's Breath Collection Unit (BCU). The partnership aims to advance the development and commercialization of this technology, with Omega providing extensive expertise in forensic drug testing. The collaboration includes hardware refinement, marketing, and preparation for multiple validation studies.
Cannabix Technologies and Omega Laboratories have entered a strategic partnership to commercialize Cannabix's marijuana breathalyzer technology. The agreement, effective from May 15, 2024, involves research and development, validation, and commercialization phases. Omega will be the exclusive laboratory in North America for analyzing Cannabix's delta9 THC breathalyzer samples for five years. Omega will receive 1,000,000 common shares and up to 11,000,000 special warrants of Cannabix upon achieving specific milestones. The partnership aims to enhance drug detection technology and expand its market reach in North America.
Cannabix Technologies Inc. has launched its new compact Breath Logix Workplace Series alcohol breath detection device designed for indoor facilities and offices. The company is in discussions with Run Rite Electronics Pty in South Africa for potential sales distribution. The device offers pre-access alcohol testing, random testing, start-of-shift testing, pre-employment testing, return-to-work testing, and post-incident testing. It automatically checks user sobriety, records identity, delivers Blood Alcohol Content (BAC) levels, sends real-time alerts, and logs user BAC for incident reporting. The device aims to promote organizational safety and reduce accidents linked to alcohol consumption.
Cannabix Technologies Inc. is collaborating with Breathalyser Sales & Service Pty in Australia to distribute its new Breath Logix Alcohol screening device. This device offers features like pre-calibrated cartridge technology, automatic BAC level detection, and real-time alerts for users in various sectors. Cannabix aims to provide an innovative solution for alcohol screening in workplaces and other settings.
FAQ
What is the current stock price of Cannabix Technol (BLOZF)?
What is the market cap of Cannabix Technol (BLOZF)?
What does Cannabix Technologies Inc. specialize in?
What is unique about Cannabix’s marijuana breathalyzer technology?
What industries benefit from Cannabix’s technologies?
How do Cannabix’s devices improve workplace safety?
What are the key features of Cannabix’s breathalyzer devices?
What challenges does Cannabix address in law enforcement?
Does Cannabix operate internationally?
What is the Breath Logix Industrial Series?
How does Cannabix’s technology save organizations money?
What makes Cannabix a key player in the substance detection market?
